RNXT

paulm1927

RNXT my best performing stock for the day.

Banksville

Had this on my watchlist… sorta didn’t watch close enough. I was preoccupied w/CALC, SELS, IOVA, RNXT, ONCY… & I guess RIME… had a $700 profit on that. Been Trying to enter again, too high right now imo. That $700 gets reinvested so not like I really feel that profit. Shoulda bought more SELS, IOVA. Those two may run higher. I like CALC @.60 for possible good gains. Been adding a lil. (I haven’t dabbled in Pennie’s for a few years. Ya’ll prob. know the story.). Seems the less I trade the better… have been holding a few years on APPL, V, SOFI. finally shed DraftKings. Coulda sold at $52… got out at $22, OUCH. Put the cash in more SOFI & finally got some XIACF ($4.45). Missed the RXT run… that can happen checking stocks in the afternoon. Tread carefully. GLTA!

Temporary_Noise_4014

Will $RNXT’s newest hires help push upcoming trials forward faster?

Muted-Extension-8521

I’m not into quick turnarounds anymore so I’m buying and holding in hopes of another interest rate cut in the next 1-2 months. $HGRAF - up to 9,500 shares after today’s purchase at $1.53 $MBOT - holding 3,500 shares long term $LAES - 600 or so shares…quantum is coming like it or not $RNXT- 1,500 shares waiting for FDA approval $BCTX - Got R/S 100 shares holding $SRFM - 600 or so shares. Electrifying Cessna’s and SurfOS My other plays are out of penny stock status. I’ve poured over months of information before investing big and you should too. No skin in the game, but I think $NUAI has an eventual path to profitability. Not financial advice.

xxesxxes

RNXT 🚀🚀🚀

MightBeneficial3302

Still early but $RNXT is already getting the network and sales side in place. If TIGeR-PaC comes through, they’ll be ready to run.. lots of upside.

Prestigious-Ant-7210

Looks like RNXT won’t publish interim results until early 2026 when the trial completes, not sure if a good or bad sign

Next_Implement_8864

Anybody watching RNXT?

klymaxx45

That’s my thoughts as well. Extremely high potential to be acquired. Although, it can be a bidding war among top biotech companies since this can enhance many chemotherapeutic drugs. Especially if it expands to many other hard tumors/cancers that traditional IV chemo can’t really saturate. The overall quality of life increasing dramatically with this platform is a huge benefit (localized chemo vs systemic) with less adverse effects and extending lives (watch for that p-value >.05 in data) is monumental. Plus, you have the whole global market. Personally, I feel $5-10 is very low. It would probably be a good valuation based on LACP alone, but this has the potential to expand into other cancers and tumors. Watch for the Cougar data to prove that. RNXT could command $1-3 billion valuation on a modest market share of pancreatic cancer alone. It would be wise to create a bidding war to be acquired for a large market by constantly increasing quarterly sales revenue to show its viability. Being acquired now would not be in the best interest of shareholders and I think they know that because they can potentially have a huge market.

pcguy2

I have about 40K shares, average 1.2X I'm VERY bullish on this company. I think the data will be positive and they have a such amazing potential as a platform for other drugs. Boston Scientific lead their series B financing. Boston has also been acquiring a BUNCH of interventional radiology companies in the past few years. If TigerPAC data is positive, I think BSCI takes RNXT for 5-10 a share within 12 months.

klymaxx45

I recently wrote a DD on RNXT. Personally, I think technical analysis is tough for micros because it doesn’t paint the whole picture. The future catalyst and data are extremely promising though. I’m invested.

klymaxx45

Accumulate. RNXT and another gem.

klymaxx45

$RNXT accumulation and hold for real wealth. I may make a DD post soon.

klymaxx45

Just sold my $BTCS today for a nice profit. Finished accumulating $RNXT for the long run. All-in on this play. Phase III results will be huge catalyst if p-value is less than 5%. If so, almost probable FDA approval. If it does happen you’re looking at a 80-200x move over the next few years. Probably a 20-30x move just on positive Phase III results. The key here is the p-value being less than 5%. There hasn’t been a breakthrough in pancreatic cancer for nearly 20 years and this will likely be next one. Pricing hasn’t even dipped into other types of cancers this device can help.

FitnessNutshell

RNXT all day baby. A hidden gem waiting for volumen to double its price 

EducatorNo4282

RNXT 🚀

FitnessNutshell

AVAV calls + RNXT 👌

FitnessNutshell

Nah! Get into RNXT boy. That’s the one

EducatorNo4282

RNXT 🚀

Global-Chemical-6570

RNXT

Motorbarge

I think $PLUG won't break out and will drop a long ways. 257,010,021 short interest says this stock is being manipulated and will crash and burn. $RNXT is only 51,468 short and the borrow fee is 61% so it has a chance but I'd be tempted to wait to see if it gets back down to 60 cents.

stockpreacher

**RNXT:** A descending triangle can be a reversal pattern, it’s also frequently a continuation pattern for downward trends. Betting on a breakout without stronger confirmation (volume or broad market support) is risky in a volatile macro environment. **PLUG:** Setup also depends on a breakout but with the market conditions we have, breakouts can easily become false signals.

Wick3db0neZ

Oof. I bought a small amount of RNXT and it's doing the same thing. Just going to hold and see if it comes back.

MightBeneficial3302

Yes, it's $RNXT, Renovorx

salmankhan690

What about RNXT?

AdaBetterThanIota

I’ve been talking about RNXT for a minute. The wedge and earnings looks pretty promising, but we will see in August

Appropriate_Luck9006

Hey there, thanks for breaking down those support levels! It's like having a secret map to navigate the market maze, right? Understanding market sentiment and managing risk with those levels can be a game-changer. This combo of TA and FA is like peanut butter and jelly — they just work together! As for **$AEMD**, that support level at $0.40 looks intriguing, especially with the volume spike indicating potential accumulation. Keep an eye on that one! **$RNXT** holding steady at $1.00 with increased volume? That's a setup that's hard to ignore. The risk-to-reward ratio there seems promising! And let's talk about the risk-taking with **$MEIL** at $0.02. The spike in volume and potential bottoming out could lead to some interesting moves. Risky, but it could pay off! And hey, have you heard about Kartoon Studios (Ticker: **$TOON**)? CEO Andy Heyward's IG updates and focus on Stan Lee's legacy are something to watch out for. Exciting times ahead with the Winnie-the-Pooh project! Now, shifting gears to Solidion Technology, Inc. (Ticker: **$STI**). Their plans to enhance EV battery capacity are electrifying, aiming to soar high in the anode materials

mjShazam98

You got any charts with your DD? How did you find out about OCGN and RNXT?

Mango_cacao

Some of the stock that were mentioned have low volume ( like RNXT); if you don’t have enough supply and demand it ‘s unnecessarily risky.

Patient-Craft-1944

I'm hodling RNXT too but will have to sell eventually.

Patient-Craft-1944

I also have RNXT on my watcchlist

AdaBetterThanIota

I am big on GLDG. I have couple swing trade posts with them. RNXT is definitely interesting. How did you find this stock?

MoneyMoves2513

$RNXT pretty new and after DD they might be bullish all week.

Longjumping-Fix-8951

How we feeling about RNXT

StockScreener777

💰💰💰Get new runners! #premarket #watchlist 06/29 $SGTX - Eli Lilly to acquire Sigilon Therapeutics in a deal worth over $300 million (+753%), $WAVE - no news + big volume (+57%) $KTRA - Awarded $2.0 Million National Institutes of Health SBIR Grant (+20%), $RNXT - Announces New Positive Interim Phase III Data (+19%) https://preview.redd.it/pycbwthrey8b1.jpeg?width=576&format=pjpg&auto=webp&v=enabled&s=06e22b3b1dd7a31ea01c9f55956573471c4f84da

StockScreener777

💰💰💰Get new runners! #premarket #watchlist 06/29 $SGTX - Eli Lilly to acquire Sigilon Therapeutics in a deal worth over $300 million (+753%), $WAVE - no news + big volume (+57%) $KTRA - Awarded $2.0 Million National Institutes of Health SBIR Grant (+20%), $RNXT - Announces New Positive Interim Phase III Data (+19%) https://preview.redd.it/i6x48ejney8b1.jpeg?width=576&format=pjpg&auto=webp&v=enabled&s=ebde4a4fcdce1f6da9a818470390950fb6961ca8

RemmingtonBlack

not going to buy any RNXT, but upvote for spelling out due diligence.

M1CHAELCHA

Is $RNXT still a hold for now?

StrategicInvestor91

RNXT is coming down. It’s run is over

AdaBetterThanIota

Much appreciated. I would personally wait for RNXT to cool off and get back down to $4.50 (assuming it doesn't keep pumping), but this isn't financial advice!!

Jacale1

I had a take on RNXT. hit my PT of 4.98 today. maybe look for an entry at abt $4.30 (if we get back there in a reasonable time period)

VRT333

Next RNXT entrance pt thoughts? Might look for a new higher support. BSGM looks attractive, might wait for some volume. I like the technicals!

AdaBetterThanIota

$RNXT up 20% this morning! Made the move I was looking for

AdaBetterThanIota

RNXT up 20% today!!!

Jacale1

my guy. a rare loss from you and an even rarer admit of a mistake from this subreddit. much praise to you for this. that being said, RNXT looks NICE. let’s go!

jloy88

PLTR - Bought at 28, sold at 13 - currently 7.5 OCGN - Bought at 10.00, sold at 5 - currently 1.7 ATER - Bought at 12.5, sold at 6. - currently 1.65 RNXT - Bought at 8.5, sold at 3.5. - currently 2.6

VisualMod

Hey /u/Slicklickfstick - I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: CAPR PGEN RNXT JAGX. We don't allow discussion of low market cap (less than 500mm) tickers to prevent pump & dump spam and scammers.

iamtracefree

LASE an IPO from last last year.. great Group Strength. They have a 2m share repurchase program. Disrupting the old sand blasting industry with their lasers. $4.91 is the highest closing high. RNXT localize treatment of solid tumors

Jacale1

I actually kinda like LASE. never heard of RNXT tho

Still_AFM

Any insight on what is going on with RNXT? Large volume relative to daily avg and up ~25%. Disclosure I sold 2/3 of my position throughout the day.

Testynut

I agree, it’s amazing how business works. I find myself looking around at normal, everyday companies where I use their products and seeing how they’re doing. I do like finding new companies as well. One that I read about that I really watch is RNXT. There are companies doing some amazing things.

NSTAG8TR

Here is a look at Fintel’s top five short squeeze candidates for the week of Dec. 6. Pioneer Power Solutions: Electrical transmission and power generation equipment company Pioneer Power Solutions Inc (NASDAQ: PPSI) tops the short squeeze leaderboard for the second straight week. Raw short interest is up over 5,000% from the previous report with 40.9% of the float short. Fintel reports a cost to borrow of 109%, up from last week’s already high 80.2%. Related Link: 5 Short Squeeze Candidates To Watch: Pioneer Power Tops List Along With Newegg, NuZee And More NuZee Inc: Coffee company NuZee Inc (NASDAQ: NUZE) remains in second place on the leaderboard for the second straight week. Fintel reports 11.2% of the float being short. Raw short interest has risen over 1,600% since the last report. The cost to borrow on shares is now 152%, up from last week’s 136%. RenovoRx Inc: Biotechnology company RenovoRx Inc (NASDAQ: RNXT) rises one place to come in third on this week’s leaderboard. Around 10% of the float is short, in line with last week’s figure. Short interest has seen a 1,400% increase going from 42,000 shares to over 643,000 shares in the latest report. The cost to borrow on shares fell to 71% for the week, compared to 101.7% last week. Grab: Rideshare and food delivery Grab Holdings Inc (NASDAQ: GRAB) has been a frequent name on the short squeeze leaderboard via the Altimeter Growth SPAC that took it public. Grab completed the SPAC merger and rejoins the leaderboard with high short interest. Fintel shows 19.7 million shares short, representing 31.5% of the total float. Short interest has increased only slightly in the latest report, which could mean short-sellers are not adding to positions. The cost to borrow on GRAB is 174%, which is the highest on the list. Cortexyme: Biotechnology company Cortexyme Inc (NASDAQ: CRTX) rejoins at fifth place. The company, which is working on treatments for Alzheimer’s Disease, has 50% of the float short. This ranks high on the Fintel list of total float percentage shorted. The cost to borrow on shares is 10%, which is why the stock comes in at fifth place and not higher.

Lets_Go_Brandon7712

Jumped in to RNXT at $7 to see if it gets some legs this afternoon 🤞🏽🤞🏽🤞🏽

BoredBillionaire

this dd got my eyes on RNXT in the first place

Equivalent_Ad_374

RNXT is listed as top five squeeze play. At least you didn’t say this guy made up the ticker like you did the last guy who posted about RNXT. https://www.streetinsider.com/dr/news.php?id=19279555&gfv=1 There’s the link to top squeeze plays and CRTX isn’t one of them.

Scary-Newspaper5801

I’m liking RNXT

itsrare1000

RNXT 😵

Sandyballz69

Oooff forgot about RNXT I was just going down the sub and the one I saw mentioned the most overall was PPSI but RNXT is killing it right now ! Lol

zendixx

RNXT as soon as possible to regain your losses

MaroBoyy_2ss

$RNXT 🚀

stock_mcstockface

Have a look at RNXT.

Thebbwe

Im mainly looking into phase 3s, this is my watchlist for next week. Rivian, RNXT,LUCID, GGPI, MESO, Ocugen, VBIV, OCUP, IVA are all my top watchlist for the week expected to have big pushes at some points in the week

Thebbwe

Last couple months there has been less interest in bio pharma markets as a whole. One approach that could be helpful to realizing all of these catalysts do exist in the bio pharma sector, would be investing in a bio pharma ETF. The approach I will take to this is to further research each potential catalyst and narrow down by which ones have the most beneficial results and biggest news. For example RNXT is on top of my list because it has reached stage 3 of FDA approval. I'd expect that most of these will have bullish results from these catalysts, but you're right if the results weren't any good from the pharmacuetical drugs a company has to offer, then it would become a bearish catalyst. However, this is a bit different than anything biopharma related before, because of the STIC conference that has come up, as a lot of these stocks haven't had any news for quite some time. Most of the Bio pharma stocks are also at floor pricing as well so I would not expect any major dips, probably all of these will have some form of gains instead, but obviously a few will be worth a lot more than others. The best way to play this safe is to put all of these markets on the watchlist and watch the chart technicals for buy signals and if they reach sell signals, sell right away. My golden cross rule and death cross rule always makes a profit even if a market has a crash, because of the rules following gap ups. Make sure that after a huge gain from any ticker, take profits because they will pump but then lose a lot of those gains after. These are just opportunities to look for next week and I'll be swing trading and day trading almost all of them for profits, After which I'll use my profits to purchase the low cost energy stocks because energy sectors have all reached their low floor prices as well. From the 20th-23rd I'm expecting a bearish period of most markets correcting quite a bit, but stocks that are at their floors won't go any lower. So invest in energy after and during that big correction happens and you won't lose money. Invest in energy until the 29th because then they will become bullish patterns, I've charted a lot of energy sector companies that appear this way and have very similar almost matching graphs. Which indicate squeezes at the end of the month. Can't really go wrong with any energy sector at the end of the month. Can't really go wrong with any bio pharma next week either, but do research and focus on the best markets for the most gains. As well as watch the graphs very closely. Buy the oversold RSI for the cheap prices, but for me IMO it's better to buy after confirmation of a golden cross, because the golden cross always leads to a gap up price and a chance of continuing uptrend, of course even after a golden cross comes up a market can correct itself, but not without first hitting a death cross, but the death cross would occur at a profitable price and higher than the golden cross started with. Thats how I handle all of my day trades for risk management. Watch to make sure the MacD is higher than the signal when both are positive and Macd is higher than signal it is a golden cross, if the macd is more negative than signal and both are negate it is a death cross. Example of golden cross numbers" Macd=10, signal=5. Example of death cross numbers, Macd= -20, signal= -10. Anything else is just normal fluctuations so watch chart patterns and formations as well, such as EMA, etc. I am a day trader so I will swing the best ones of these markets based on the technical charts. I'm just letting everyone know what to expect next week, Biopharma is one of the most bullish sectors, as well as auto and EV. A reason why the golden cross and death cross rule works so well, is because the algo ai they use to trade, all utilize the same rules so these signals are like racing with the algos.

vadershouse88

Check out NUZE & RNXT! Looking juicy

ParsleyExtension9166

Could really use your help with RNXT. Us little guys got trapped but it's starting to move again - fingers crossed.